Most healthcare deals do not die over price. They stall in due diligence when a buyer’s accountants start pulling your earnings apart and find numbers that don’t hold up. That moment delays a close, triggers a price cut, or ends the deal.
Buyers scrutinize healthcare earnings harder than almost any other sector. Reimbursement timing, payer mix, owner compensation, coding exposure. Each one sits in your financials and invites questions. A quality of earnings report answers those questions before you go to market, so you show up with answers instead of surprises.
What Is a Quality of Earnings Report?
A quality of earnings report measures how much of your reported profit reflects sustainable, repeatable performance. It separates the earnings that continue under new ownership from numbers inflated by one-time events, accounting choices, or owner-specific arrangements.
A QoE report tests your profits’ durability. It asks whether last year’s EBITDA came from normal operations or from a one-time contract, a favorable payer adjustment, or expenses the owner absorbed personally. The analysis rebuilds your earnings into a defensible, normalized figure a buyer can trust.
This matters more in physician-owned and clinical practices. Revenue depends on reimbursement cycles, provider productivity, and shifting payer relationships. A QoE report shows which earnings survive the transition and which depend on the current owner sitting in the chair.
Quality of Earnings vs. Audit: Why the Difference Matters
An audit confirms your financial statements comply with accounting standards. A quality of earnings report reveals whether those compliant numbers represent real, ongoing cash generation. They answer different questions.
An audit looks backward and verifies compliance. A QoE report looks forward and tests cash quality, asking whether earnings hold once you step away. That forward lens matters when a buyer sets a price.
An audit alone rarely satisfies a buyer. Clean statements can still hide concentration risk, thin margins, or aggressive revenue recognition. In a healthcare sale, the two work together. The audit confirms accuracy, and the QoE report confirms the earnings behind that accuracy will continue.
Why Healthcare Businesses Get Scrutinized Differently
Healthcare financials carry risks most industries do not. Payer mix, reimbursement timing, and revenue recognition all affect when and whether revenue turns into cash. A practice with strong billings but slow collections looks different once a buyer models real cash flow.
Owner compensation and add-backs draw close attention. Buyers question every adjustment, from a spouse on payroll to personal expenses run through the business. Each add-back you cannot defend lowers the earnings a buyer will pay for.
Regulatory, coding, and compliance exposure live in the numbers too. A coding pattern that inflates revenue today becomes a liability under new ownership. Concentration risk makes it worse. If one payer or referral source drives most of your revenue, a buyer discounts your earnings quality to match.
What a Sell-Side QoE Report Uncovers Before Buyers Do
A sell-side QoE report puts you in control of the story. It sets normalized EBITDA and documents defensible add-backs, so you enter negotiations with a figure you can stand behind rather than one a buyer hands you.
It surfaces working capital trends that shape deal terms. Buyers set a working capital target at close, and a report showing your normal patterns keeps you from leaving cash on the table at settlement.
Most of all, it finds hidden liabilities and revenue issues before a buyer does. A collections problem, a shaky add-back, a revenue recognition gap. Each is far easier to fix on your timeline than to explain mid-diligence. Problems you solve early stop becoming leverage for the other side.
How a Quality of Earnings Report Protects Your Valuation
Clean, documented earnings support your asking price. When a buyer can trace your EBITDA and verify your add-backs, your quoted number holds. Unsupported figures invite skepticism, and skepticism lowers offers.
A QoE report cuts price adjustments and retrades. Buyers retrade when diligence uncovers something they didn’t expect. A report that already accounts for those issues removes the surprise and the excuse for a lower number.
It also shortens diligence and holds deal momentum. Deals lose energy when buyers wait weeks for answers. Credible data up front keeps the process moving and strengthens your position because you argue from evidence, not assertion.
When Should You Commission a QoE Report?
Commission it before you go to market, not during negotiations. Doing the work early gives you time to correct issues, document add-backs, and present a clean picture from the first buyer conversation.
Early preparation separates fixing a problem quietly from explaining it under pressure. A collections pattern or a compensation adjustment can take months to normalize, and you want that done before anyone opens your books.
Watch for signs you are nearing a sale inflection point. Unsolicited buyer interest. A succession decision. A private equity rollup moving into your market. Even if a sale is years out, a QoE report gives you a baseline and a roadmap to build value before you ever list.
What Does a Quality of Earnings Report Cost?
The cost of a quality of earnings report depends on the scope of work. For most healthcare practices, a sell-side report runs from the low tens of thousands upward, depending on how deep the analysis goes and the state of your records.
Practice size, complexity, and payer mix drive the number. A single-site practice with clean books and simple payer relationships costs less than a multi-location group with varied contracts, several providers, and layered compensation.
Weigh the cost against the deal value it protects. One avoided retrade, or one defended add-back,k often beats the entire fee. When a report keeps a six- or seven-figure valuation intact, the investment pays for itself at closing.
Is a QoE Report Right for Your Situation?
A QoE report makes clear sense when you expect a competitive sale, a private equity buyer, or a valuation built on normalized earnings. These buyers run rigorous diligence, and you need to match it.
A lighter financial review may be enough for a small internal transfer or a sale to a known party at a pre-agreed price. The deeper the scrutiny you expect, the more a full report earns its place.
Before you commit, ask who your likely buyer is, how clean your records are, and where your earnings carry risk. Then fit the answer into your broader exit readiness plan. A QoE report works best as one part of a deliberate preparation process.
Walk Into Diligence With Earnings That Hold
Buyers will test every number you hand them, and the ones that crack cost you price, time, or the deal itself. Inflection 360 helps healthcare owners find the weak spots in their earnings, defend every add-back, and go to market with figures that survive diligence. Do not let a buyer’s accountants be the first to find the problems.
Start building your exit plan today with Inflection 360’s strategic alternatives and exit strategy team.
